Some companies are being paid a premium to keep their medicines on the PBS and well supplied while others are having their prices slashed to the point they are exiting the program. Is anyone else confused? And, why Ernest Hemingway provides the best metaphor for how people should approach the period ahead - the fisherman, the marlin and the sharks.
Latest Video
New Stories
-
The 'Dispatched' Week in Review'- 14 June
June 15, 2026 - - Podcast -
High Court to decide on patent‑term extensions for formulations as GBMA intervenes
June 15, 2026 - - Latest News -
Approach policy and pricing negotiations like planning for a product launch
June 15, 2026 - - Latest News -
LifeSciences Australia honours outstanding professionals at MTP Sector Awards 2026
June 12, 2026 - - Latest News -
State and Territory ministers warn against centralising NDIS power
June 12, 2026 - - Latest News -
The opportunity to change the conversation, the negotiating dynamic, and take some control
June 12, 2026 - - Latest News -
'The changes could cause irreversible damage to our vibrant and world-leading biotech, medtech and health tech sector'
June 12, 2026 - - Australian Biotech

